Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01968590 · ClinicalTrials.gov registry record · Phase 2
Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)
A Phase 2 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT01968590 is a Phase 2 study that was terminated before completion, run by University of Utah. The registered enrollment target is 26 participants.
The verdict
NCT01968590, a Phase 2 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
This clinical trial is conducted by one of 4 locations; University of British Columbia (Vancouver, CA), University of Utah (Salt Lake City, UT, USA), University of Cincinnati (Cincinnati, OH, USA), and University of Hamburg (Hamburg, Germany). Adults with NF1 have a higher risk of osteopenia and osteoporosis, a condition of low bone density that can lead to fragile bones and bone breakage. People with NF1 also have lower vitamin D levels than unaffected individuals. Vitamin D is important for normal bone health, but studies to improve bone health by vitamin D supplementation in people with NF1 have not been tried. The purpose of this study is to treat adults with NF1 who have insufficient serum vitamin D levels with 2 different doses of vitamin D supplementation to determine if vitamin D supplementation ameliorates the usual loss of bone mineral density over 2 years.
Interventions
- DRUG Cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2017-08-16 |
| Est. Completion | 2022-01-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01968590
The ClinicalTrials.gov registry entry for NCT01968590 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cholecalciferol is the first listed.
NCT01968590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01968590 about?
NCT01968590 is a clinical study titled "Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)". This clinical trial is conducted by one of 4 locations; University of British Columbia (Vancouver, CA), University of Utah (Salt Lake City, UT, USA), University of Cincinnati (Cincinnati, OH, USA), and University of Hamburg (Hamburg, Germany). Adults with NF1 have a higher risk of osteopenia and os...
What is the current status of trial NCT01968590?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2017-08-16. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT01968590?
The interventions under investigation include: Cholecalciferol (DRUG).
Who is sponsoring clinical trial NCT01968590?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.